Allianz Asset Management GmbH lifted its stake in shares of Davita Inc (NYSE:DVA) by 4,066.3% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 177,319 shares of the company’s stock after buying an additional 173,063 shares during the quarter. Allianz Asset Management GmbH owned about 0.10% of Davita worth $12,811,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently bought and sold shares of DVA. OppenheimerFunds Inc. raised its stake in Davita by 5,292.6% in the 4th quarter. OppenheimerFunds Inc. now owns 1,873,918 shares of the company’s stock worth $135,391,000 after purchasing an additional 1,839,168 shares in the last quarter. First Trust Advisors LP raised its stake in Davita by 5.1% in the 4th quarter. First Trust Advisors LP now owns 650,039 shares of the company’s stock worth $46,965,000 after purchasing an additional 31,743 shares in the last quarter. Schwab Charles Investment Management Inc. raised its stake in Davita by 2.4% in the 4th quarter. Schwab Charles Investment Management Inc. now owns 587,575 shares of the company’s stock worth $42,453,000 after purchasing an additional 14,040 shares in the last quarter. California Public Employees Retirement System raised its stake in Davita by 4.4% in the 4th quarter. California Public Employees Retirement System now owns 511,756 shares of the company’s stock worth $36,974,000 after purchasing an additional 21,624 shares in the last quarter. Finally, Schroder Investment Management Group raised its stake in Davita by 769.0% in the 3rd quarter. Schroder Investment Management Group now owns 434,191 shares of the company’s stock worth $25,387,000 after purchasing an additional 384,224 shares in the last quarter. Institutional investors own 85.80% of the company’s stock.
Several analysts have weighed in on DVA shares. JPMorgan Chase lifted their price objective on shares of Davita from $4.90 to $84.00 and gave the stock a “strong-buy” rating in a research note on Thursday, December 7th. Citigroup upgraded shares of Davita from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $67.71 to $82.00 in a research note on Monday, December 11th. Robert W. Baird reiterated a “buy” rating and issued a $95.00 price objective (up previously from $82.00) on shares of Davita in a research note on Friday, January 12th. SunTrust Banks set a $70.00 price objective on shares of Davita and gave the stock a “hold” rating in a research note on Thursday, December 7th. Finally, Raymond James Financial upgraded shares of Davita from an “outperform” rating to a “strong-buy” rating and lifted their price objective for the stock from $65.00 to $84.00 in a research note on Thursday, December 7th. Two research analysts have rated the stock with a sell rating, five have given a hold rating, four have issued a buy rating and two have assigned a strong buy rating to the company. The stock currently has an average rating of “Hold” and an average price target of $79.30.
Shares of NYSE:DVA traded down $2.15 during midday trading on Monday, hitting $63.79. The stock had a trading volume of 2,434,508 shares, compared to its average volume of 1,571,323. The stock has a market capitalization of $12,001.08, a PE ratio of 19.21, a PEG ratio of 0.95 and a beta of 1.09. The company has a current ratio of 2.88, a quick ratio of 2.82 and a debt-to-equity ratio of 1.87. Davita Inc has a fifty-two week low of $52.51 and a fifty-two week high of $80.71.
Davita (NYSE:DVA) last issued its earnings results on Tuesday, February 13th. The company reported $0.92 EPS for the quarter, missing the consensus estimate of $0.94 by ($0.02). The firm had revenue of $2.78 billion during the quarter, compared to analyst estimates of $3.90 billion. Davita had a net margin of 4.65% and a return on equity of 12.86%. During the same quarter in the previous year, the firm posted $0.98 earnings per share. research analysts predict that Davita Inc will post 4.15 EPS for the current fiscal year.
In related news, insider James K. Hilger sold 3,572 shares of Davita stock in a transaction that occurred on Tuesday, January 16th. The shares were sold at an average price of $78.95, for a total transaction of $282,009.40. Following the sale, the insider now directly owns 33,649 shares of the company’s stock, valued at approximately $2,656,588.55. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 2.00% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This article was first published by Enterprise Leader and is the sole property of of Enterprise Leader. If you are reading this article on another site, it was stolen and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this article can be viewed at https://theenterpriseleader.com/2018/04/02/allianz-asset-management-gmbh-purchases-173063-shares-of-davita-inc-nysedva.html.
DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.